Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Omicia's Opal Clinical; Genetworx' Personal Health Panel


Omicia has launched Opal Clinical, a software solution for diagnostic testing. The software includes algorithms for interpreting next-generation sequencing data, including gene panels, exomes, and whole-genomes. The software is both HIPAA and CLIA compliant and can be integrated with LIMS and electronic health records.

Genetworx has launched its Personal Health Panel, a next-generation sequencing-based test to detect pathogens that cause infectious diseases such as sexually transmitted diseases and viruses that infect the gastrointestinal tract. It will also detect pathogens that are resistant to common drugs.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.